Abstract
Tumor necrosis factor α antagonists have proven efficacious for a variety of autoimmune-mediated diseases. However, recent data have highlighted the risk of invasive fungal infections with their use. These agents are typically discontinued when infectious complications occur during therapy; however, the immune reconstitution inflammatory syndrome (IRIS) may be seen after drug cessation. We describe the 1st case of IRIS secondary to cryptococcal pneumonia after cessation of adalimumab.
Original language | English (US) |
---|---|
Pages (from-to) | 327-330 |
Number of pages | 4 |
Journal | Diagnostic Microbiology and Infectious Disease |
Volume | 64 |
Issue number | 3 |
DOIs | |
State | Published - Jul 2009 |
Keywords
- Adalimumab
- Cryptococcus
- Immune reconstitution
- TNF-α inhibitors
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases